Discovering Novel Brain Cells: A Game-Changer for Mental Illness Treatment
Recent research shows that “nerve glue” plays key roles in mental health issues like depression and schizophrenia.
This research highlights the potential for personalized medicine that could improve treatments by considering individual cellular behaviors.
Neuroglia, often called glia or “nerve glue,” are a diverse group of cells in the brain. Traditionally, research focused primarily on neurons. However, over the last few decades, studies have increasingly explored the functions of neuroglia.
Scientists now suspect that glia cells significantly influence psychiatric conditions. “When we think of the brain, we usually consider neurons, but they make up only about 50% of brain matter,” says Sukumar Vijayaraghavan, PhD, a professor at the University of Colorado School of Medicine.
Understanding Glial Cell Signaling
Initially, scientists viewed neuroglia as supportive cells that maintained a healthy environment for neurons. Recent findings show that glia have their own unique signaling system. Instead of electrical signals, they use calcium signals.
“We started to ask what these cells actually do,” Vijayaraghavan explains. The answer reveals that they do much more than previously understood.
Bringing Neuroscience into Psychiatry
A specific type of glia, known as astrocytes, are closely linked to the function of synapses in neurons. Their role in the brain’s stress response suggests a connection to mental health issues.
In a 2017 study from China, researchers found that compromised astrocyte function in animal models led to depression-like symptoms. Vijayaraghavan and Andrew Novick, MD, PhD, also analyze glia cells’ roles in psychiatric disorders. They note, “Astrocytes from individuals with psychiatric disorders show different traits than those from healthy individuals.”
For instance, in a study involving schizophrenia patients, astrocytes displayed deficiencies in glutamate signaling. When treated with clozapine, a medication, glutamate signaling normalized only in patients who responded well to the treatment.
Understanding glia can enhance clinical approaches. Many psychiatric disorders are defined by symptoms, but symptoms can arise from various underlying causes.
“We’re integrating neuroscience into psychiatry to explore the specific mechanisms at play rather than focusing solely on symptoms,” Vijayaraghavan states.
Technological Advancements and Future Directions
Novick emphasizes the importance of explaining to patients their psychiatric symptoms and potential brain malfunctions. Currently, many patients lack clarity about their conditions.
“If a doctor treats a stomachache without understanding its cause, that’s not satisfactory,” Novick says. “We aim to identify the causes of psychiatric diseases, not just their treatments.”
Investigating glial cells may assist in achieving these objectives. “Research suggests a connection between astrocytes and depression,” Novick adds. This offers valuable insights into how depression medications may work.
New technologies allow researchers to examine glial cells more deeply. They can convert easily obtained skin or blood cells into cells of interest.
Potential for Personalized Medicine
Future research could lead to personalized treatment options. “We could generate astrocytes from individuals with schizophrenia or depression, identify dysfunctions, and develop tailored therapies,” Vijayaraghavan suggests.
Reference: “Under the Microscope: Nerve Glue and the Evolution of Psychiatric Neuroscience” by Sukumar Vijayaraghavan, David A. Ross, and Andrew M. Novick, 1 November 2024, Biological Psychiatry.